115 related articles for article (PubMed ID: 3359436)
1. Estrogen receptor and hormone responsiveness of medullary thyroid carcinoma cells in continuous culture.
Yang K; Pearson CE; Samaan NA
Cancer Res; 1988 May; 48(10):2760-3. PubMed ID: 3359436
[TBL] [Abstract][Full Text] [Related]
2. Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells.
Bezwoda WR; Meyer K
Cancer Res; 1990 Sep; 50(17):5387-91. PubMed ID: 2386944
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
4. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
5. Effects of tamoxifen and somatostatin analogue on growth of human medullary, follicular, and papillary thyroid carcinoma cell lines: tissue culture and nude mouse xenograft studies.
Weber CJ; Marvin M; Krekun S; Koschitzky T; Karp F; Benson M; Feind CR
Surgery; 1990 Dec; 108(6):1065-71. PubMed ID: 1978945
[TBL] [Abstract][Full Text] [Related]
6. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K
Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211
[TBL] [Abstract][Full Text] [Related]
7. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
[TBL] [Abstract][Full Text] [Related]
8. Presence of estrogen binding sites and growth-stimulating effect of estradiol in the human myelogenous cell line HL60.
Danel L; Cordier G; Revillard JP; Saez S
Cancer Res; 1982 Nov; 42(11):4701-5. PubMed ID: 6957260
[TBL] [Abstract][Full Text] [Related]
9. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
Benz C; Hollander C; Miller B
Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation.
Shao ZM; Sheikh MS; Rishi AK; Dawson MI; Li XS; Wilber JF; Feng P; Fontana JA
Exp Cell Res; 1995 May; 218(1):1-8. PubMed ID: 7737350
[TBL] [Abstract][Full Text] [Related]
11. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
12. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
13. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
14. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Res; 1976 Dec; 36(12):4595-601. PubMed ID: 1000504
[TBL] [Abstract][Full Text] [Related]
15. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
17. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
19. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
Goldenberg GJ; Froese EK
Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
Reddel RR; Murphy LC; Hall RE; Sutherland RL
Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
